CA1041909A - Pharmaceutical composition containing p-alkanoyltoluene - Google Patents
Pharmaceutical composition containing p-alkanoyltolueneInfo
- Publication number
- CA1041909A CA1041909A CA220,658A CA220658A CA1041909A CA 1041909 A CA1041909 A CA 1041909A CA 220658 A CA220658 A CA 220658A CA 1041909 A CA1041909 A CA 1041909A
- Authority
- CA
- Canada
- Prior art keywords
- pharmaceutical composition
- composition according
- dosage form
- compound
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
- C07C49/807—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen all halogen atoms bound to the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44526574A | 1974-02-25 | 1974-02-25 | |
| US49586274A | 1974-08-08 | 1974-08-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1041909A true CA1041909A (en) | 1978-11-07 |
Family
ID=27034241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA220,658A Expired CA1041909A (en) | 1974-02-25 | 1975-02-24 | Pharmaceutical composition containing p-alkanoyltoluene |
Country Status (8)
| Country | Link |
|---|---|
| AU (1) | AU500550B2 (enExample) |
| CA (1) | CA1041909A (enExample) |
| DE (1) | DE2506456A1 (enExample) |
| FR (1) | FR2261758B1 (enExample) |
| GB (1) | GB1504207A (enExample) |
| IE (1) | IE40941B1 (enExample) |
| IL (1) | IL46690A (enExample) |
| NL (1) | NL7502079A (enExample) |
-
1975
- 1975-02-15 DE DE19752506456 patent/DE2506456A1/de not_active Withdrawn
- 1975-02-18 FR FR7504947A patent/FR2261758B1/fr not_active Expired
- 1975-02-21 NL NL7502079A patent/NL7502079A/xx not_active Application Discontinuation
- 1975-02-24 IL IL46690A patent/IL46690A/en unknown
- 1975-02-24 GB GB7711/75A patent/GB1504207A/en not_active Expired
- 1975-02-24 CA CA220,658A patent/CA1041909A/en not_active Expired
- 1975-02-24 IE IE380/75A patent/IE40941B1/xx unknown
- 1975-02-25 AU AU78545/75A patent/AU500550B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IE40941L (en) | 1975-08-25 |
| NL7502079A (nl) | 1975-08-27 |
| AU500550B2 (en) | 1979-05-24 |
| GB1504207A (en) | 1978-03-15 |
| DE2506456A1 (de) | 1975-08-28 |
| AU7854575A (en) | 1976-08-26 |
| IL46690A (en) | 1977-07-31 |
| FR2261758A1 (enExample) | 1975-09-19 |
| IE40941B1 (en) | 1979-09-12 |
| FR2261758B1 (enExample) | 1980-01-11 |
| IL46690A0 (en) | 1975-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR910004572B1 (ko) | 경구용 당뇨병 치료제 제형의 제조방법 | |
| RU1816213C (ru) | Способ получени твердой лекарственной формы с регулируемым выделением лекарственного средства | |
| US5674893A (en) | Method for preventing reducing or risk of onset of cerebrovascular events employing an HMG CoA reductase inhibitor | |
| US5487900A (en) | Stabilized vitamin D preparation | |
| EP0231826A2 (en) | Theophylline sustained release tablet | |
| CA2039763A1 (en) | Combination of pravastatin and a fibric acid derivative, and method for treating dyslipidemia using such combination | |
| CA2469019C (en) | Pharmaceutical composition comprising a 5ht1 receptor agonist | |
| JPH0640928A (ja) | アントシアノシド類を含有する経口医薬組成物 | |
| EP0671170A1 (en) | Use of pravastatin for slowing progression coronary artery atherosclerosis | |
| CN101431982A (zh) | 口服液体组合物 | |
| US20060166959A1 (en) | Pharmaceutical compositions based on azetidine derivatives | |
| AU781828B2 (en) | Dosing regimens for lasofoxifene | |
| EP0373507A1 (en) | Combination of an HMG CoA reductase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination | |
| JP4212272B2 (ja) | トリグリセリド低下剤組成物 | |
| KR960007753B1 (ko) | 피페리디노알칸올 유도체용 제약 조성물 | |
| EP0521057B1 (en) | Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use | |
| CA1165241A (en) | Sustained release theophylline tablet having reduced bulk | |
| IL46690A (en) | Pharmaceutical compositions containing &-(2,2-dialkyl propanolyl)toluene derivatives | |
| Shargel et al. | Effect of antacid on bioavailability of theophylline from rapid and timed‐release drug products | |
| GB2061111A (en) | Long acting pharmaceutical composition | |
| CN107737105A (zh) | 一种鼻腔用盐酸氮卓斯汀组合物喷雾剂及生产工艺 | |
| CA1048934A (en) | Organic compounds | |
| US3968247A (en) | Substituted or unsubstituted p-alkanoyl toluenes as anti-diabetic agents | |
| JP4212271B2 (ja) | 血中脂質改善剤組成物 | |
| US4146648A (en) | Chemotherapeutic composition |